Interventional strategy preferable for unstable coronary artery disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1355, 2002-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended dalteparin sodium effective in unstable coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1353, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Editorial: The Advances in Treatment for Coronary Artery Disease, Voices from Interventional Cardiologists at the Fortieth Year of Percutaneous Coronary Intervention

By  

Current Pharmaceutical Design, Vol. 24, Iss. 4, 2018-04 ,pp. : 379-380

Bentham Science Publishers

Access to resources Recommend Favorite

NSAIDs increase CV risk in coronary artery disease

By  

Reactions Weekly, Vol. 1, Iss. 1363, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Candesartan CREATEs promise in coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Celecoxib: beneficial effects in coronary artery disease

By  

Inpharma, Vol. 1, Iss. 1374, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite